Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Hydroxyisohexyl 3-cyclohexene Carboxaldehyde (Lyral®) Dose Response Study

NCT02028182 is registered in ClinicalTrials.gov with Allerderm as lead sponsor.

NCT NCT02028182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02028182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Hydroxyisohexyl 3-cyclohexene Carboxaldehyde (Lyral®) Dose Response Study
Lead sponsor
Allerderm
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2013
Completion date
June 30, 2013
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contact dermatitis